alpha-5/beta-1 integrin fibronectin inhibitor (Morphic Therapeutics)

N/A

Report date: 2025/06/11 10:30:43
NME

Base Information

Drug Namealpha-5/beta-1 integrin fibronectin inhibitor (Morphic Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-5/beta-1 inhibitors
TargetsIntegrin alpha-5/beta-1
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMorphic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphic Therapeutic Inc
Inactive CompaniesN/A
Active IndicationsHypertension, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A